These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12611795)

  • 1. Olanzapine toxicity in unconjugated hyperbilirubinaemia (Gilbert's syndrome).
    Martín-Escudero JC; Dueñas-Laíta A; Pérez-Castrillón JL; Herreros-Fernández V
    Br J Psychiatry; 2003 Mar; 182():267. PubMed ID: 12611795
    [No Abstract]   [Full Text] [Related]  

  • 2. Speech disturbance and marked decrease in function seen in several older patients on olanzapine.
    Gaile S; Noviasky JA
    J Am Geriatr Soc; 1998 Oct; 46(10):1330-1. PubMed ID: 9777929
    [No Abstract]   [Full Text] [Related]  

  • 3. Low blood glucose and olanzapine.
    Budman CL; Gayer AI
    Am J Psychiatry; 2001 Mar; 158(3):500-1. PubMed ID: 11230004
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuropletic malignant syndrome and olanzapine.
    Sierra-Biddle D; Herran A; Diez-Aja S; Gonzalez-Mata JM; Vidal E; Diez-Manrique F; Vazquez-Barquero JL
    J Clin Psychopharmacol; 2000 Dec; 20(6):704-5. PubMed ID: 11106147
    [No Abstract]   [Full Text] [Related]  

  • 5. Olanzapine/risperidone and diabetes risk.
    Lee DW; Fowler RB
    J Clin Psychiatry; 2003 Jul; 64(7):847-8; author reply 848. PubMed ID: 12934988
    [No Abstract]   [Full Text] [Related]  

  • 6. Olanzapine and pancreatitis.
    Hagger R; Brown C; Hurley P
    Br J Psychiatry; 2000 Dec; 177():567. PubMed ID: 11102343
    [No Abstract]   [Full Text] [Related]  

  • 7. Olanzapine-induced agranulocytosis: a case report and review of the literature.
    Tolosa-Vilella C; Ruiz-Ripoll A; Mari-Alfonso B; Naval-Sendra E
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):411-4. PubMed ID: 11817522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine induced "typical" neuroleptic malignant syndrome.
    Goveas JS; Hermida A
    J Clin Psychopharmacol; 2003 Feb; 23(1):101-2. PubMed ID: 12544383
    [No Abstract]   [Full Text] [Related]  

  • 9. Olanzapine-associated priapism.
    Gordon M; de Groot CM
    J Clin Psychopharmacol; 1999 Apr; 19(2):192. PubMed ID: 10211928
    [No Abstract]   [Full Text] [Related]  

  • 10. [Neuroleptic malignant syndrome and atypical antipsychotics].
    Canora Lebrato J; Bermúdez García JM; Alvarez García ML; Rico Irles J
    Med Clin (Barc); 2000 Sep; 115(7):279. PubMed ID: 11013157
    [No Abstract]   [Full Text] [Related]  

  • 11. Case report of withdrawal syndrome after olanzapine discontinuation.
    Nayudu SK; Scheftner WA
    J Clin Psychopharmacol; 2000 Aug; 20(4):489-90. PubMed ID: 10917413
    [No Abstract]   [Full Text] [Related]  

  • 12. Olanzapine and rhabdomyolysis.
    Shuster J
    Nursing; 2000 Sep; 30(9):87. PubMed ID: 11022553
    [No Abstract]   [Full Text] [Related]  

  • 13. Olanzapine and tardive dyskinesia.
    Woods SW
    Br J Psychiatry; 1999 Oct; 175():391-2. PubMed ID: 10789313
    [No Abstract]   [Full Text] [Related]  

  • 14. Olanzapine-induced hyperventilation: case report.
    Sattar SP; Gastfriend DR
    J Psychiatry Neurosci; 2002 Sep; 27(5):360-3. PubMed ID: 12271791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body weight gain, insulin, and leptin in olanzapine-treated patients.
    Baptista T; Beaulieu S
    J Clin Psychiatry; 2001 Nov; 62(11):902-4. PubMed ID: 11775052
    [No Abstract]   [Full Text] [Related]  

  • 16. Olanzapine can worsen parkinsonism.
    Jiménez-Jiménez FJ; Tallón-Barranco A; Ortí-Pareja M; Zurdo M; Porta J; Molina JA
    Neurology; 1998 Apr; 50(4):1183-4. PubMed ID: 9566425
    [No Abstract]   [Full Text] [Related]  

  • 17. Pustular eruption induced by olanzapine, a novel antipsychotic agent.
    Adams BB; Mutasim DF
    J Am Acad Dermatol; 1999 Nov; 41(5 Pt 2):851-3. PubMed ID: 10534668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality outcomes after busulfan-containing conditioning treatment and haemopoietic cell transplantation in patients with Gilbert's syndrome: a retrospective cohort study.
    McDonald GB; Evans AT; McCune JS; Schoch G; Ostrow JD; Gooley TA
    Lancet Haematol; 2016 Nov; 3(11):e516-e525. PubMed ID: 27968820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fever, delirium, autonomic instability, and monocytosis associated with olanzapine.
    Robinson RL; Burk MS; Raman S
    J Postgrad Med; 2003; 49(1):96. PubMed ID: 12865583
    [No Abstract]   [Full Text] [Related]  

  • 20. Tardive dyskinesia associated with olanzapine.
    Herrán A; Vázquez-Barquero JL
    Ann Intern Med; 1999 Jul; 131(1):72. PubMed ID: 10391826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.